RCG Mississippi, INC.
RCG Mississippi, INC. was paid $3.23M by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 89% of everything it billed.
STARKVILLE, MS 39759
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,437 | $504K | |
| 2019 | 37,811 | $533K | |
| 2020 | 36,743 | $359K | |
| 2021 | 33,876 | $319K | |
| 2022 | 49,596 | $532K | |
| 2023 | 45,573 | $608K | |
| 2024incomplete | 32,105 | $379K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 89% | 54,988 | 4,273 | $2.86M |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 3.9% | 8,779 | 863 | $126K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 2.5% | 5,147 | 2,674 | $82K |
| 83970 | <1% | 3,713 | 3,260 | $31K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 9,929 | 2,137 | $18K |
| 84520 | <1% | 9,289 | 3,893 | $9K | |
| 83550 | <1% | 3,973 | 3,562 | $8K | |
| 85018 | <1% | 13,176 | 3,989 | $8K | |
| 82728 | <1% | 3,056 | 2,651 | $7K | |
| 83540 | <1% | 4,343 | 3,860 | $7K | |
| 82310 | <1% | 4,872 | 3,875 | $7K | |
| 80051 | <1% | 2,376 | 2,193 | $7K |
45 more codes
| 84100 | <1% | 5,834 | $7K | |
| 85027 | <1% | 4,160 | $6K | |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 19,532 | $6K |
| 82040 | <1% | 4,437 | $6K | |
| 82565 | <1% | 4,363 | $6K | |
| 87340 | <1% | 1,212 | $4K | |
| 85045 | <1% | 3,949 | $3K | |
| 82947 | <1% | 3,060 | $3K | |
| 84155 | <1% | 3,585 | $3K | |
| 83735 | <1% | 1,503 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 21,198 | $2K |
| 84075 | <1% | 1,508 | $2K | |
| 82108 | <1% | 324 | $2K | |
| 84460 | <1% | 1,000 | $1K | |
| 84450 | <1% | 999 | $1K | |
| 84466 | <1% | 275 | $1K | |
| 86706 | <1% | 424 | $884.61 | |
| 90732 | <1% | 39 | $791.16 | |
| 82374 | <1% | 1,923 | $653.46 | |
| 82435 | <1% | 1,916 | $608.58 | |
| 84132 | <1% | 1,965 | $580.93 | |
| 82746 | <1% | 270 | $572.03 | |
| 84295 | <1% | 1,892 | $506.61 | |
| 90688 | <1% | 85 | $334.70 | |
| 90686 | <1% | 130 | $309.50 | |
| 86803 | <1% | 215 | $282.40 | |
| 90662 | <1% | 47 | $274.77 | |
| 90740 | <1% | 20 | $268.24 | |
| 0012A | <1% | 31 | $249.56 | |
| 0064A | <1% | 24 | $240.20 | |
| 82607 | <1% | 29 | $185.47 | |
| 0011A | <1% | 20 | $100.82 | |
| 82247 | <1% | 166 | $9.04 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 245 | $0.00 |
| 80061 | Lipid panel | 0% | 134 | $0.00 |
| 82465 | 0% | 82 | $0.00 | |
| 90682 | 0% | 19 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 0% | 57,654 | $0.00 |
| J3490 | Unclassified drugs | 0% | 1,400 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 243 | $0.00 |
| 90739 | 0% | 81 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 39 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 319 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 0% | 101 | $0.00 |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.